Skip to content

Clinical trials

Terminated Phase 3 Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 3 Status: Terminated Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20081
20102
20131
20141
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Inovio Pharmaceuticals2
Abbott1
Daiichi Sankyo1
Hoffmann-La Roche1
InterMune1
LEO Pharma1
Pfizer1
Xian-Janssen Pharmaceutical Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma12
Neoplasms9
Carcinoma, Non-Small-Cell Lung5
Carcinoma, Squamous Cell3
Head and Neck Neoplasms3
Neoplasms by Site3
Adenocarcinoma2
Liver Neoplasms2
Lung Diseases2
Lung Neoplasms2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.